Kepler Capital Markets set a CHF 230 target price on Roche Holding Ltd. (VTX:ROG) in a report published on Monday morning. The brokerage currently has a neutral rating on the healthcare company’s stock.

ROG has been the subject of several other reports. Barclays PLC set a CHF 305 price objective on Roche Holding and gave the stock a buy rating in a research note on Tuesday, June 13th. J P Morgan Chase & Co reissued a buy rating on shares of Roche Holding in a research note on Wednesday, June 7th. Deutsche Bank AG set a CHF 273 price objective on Roche Holding and gave the stock a buy rating in a research note on Tuesday, June 6th. HSBC Holdings plc set a CHF 215 price objective on Roche Holding and gave the stock a sell rating in a research note on Tuesday, June 6th. Finally, Goldman Sachs Group, Inc. (The) set a CHF 335 price objective on Roche Holding and gave the stock a buy rating in a research note on Tuesday, June 6th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and eight have issued a buy rating to the stock. The company currently has an average rating of Hold and a consensus price target of CHF 267.53.

Roche Holding (ROG) opened at 242.90 on Monday. Roche Holding has a 52-week low of CHK 218.30 and a 52-week high of CHK 273.00. The firm has a market cap of CHK 207.26 billion and a price-to-earnings ratio of 21.57. The firm’s 50 day moving average price is CHK 243.48 and its 200 day moving average price is CHK 252.48.

WARNING: This piece of content was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of international trademark and copyright laws. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/09/14/kepler-capital-markets-analysts-give-roche-holding-ltd-rog-a-chf-230-price-target.html.

About Roche Holding

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Stock Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related stocks with our FREE daily email newsletter.